Viewing Study NCT02733250


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-24 @ 5:56 AM
Study NCT ID: NCT02733250
Status: COMPLETED
Last Update Posted: 2021-02-16
First Post: 2016-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module